Interestingly, a study by Wang et al. [64] reported that Aβ status appeared to affect the association between [18F]AV-1451 retention and cerebral volume; only Aβ-positive participants (CN subjects and AD patients) showed a significant association between tau imaging and volume loss. The gene discussed is MAPT; the disease is Alzheimer disease.